Patents Assigned to ENERGENESIS BIOMEDICAL CO., LTD.
  • Method for activating AMPK and the use of adenine
    Patent number: 11497748
    Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: November 15, 2022
    Assignee: Energenesis Biomedical Co., Ltd.
    Inventors: Han-Min Chen, Cheng-Yi Kuo, Chun-Fang Huang, Jiun-Tsai Lin
  • Method for enhancing wound healing by administrating adenine
    Patent number: 11311546
    Abstract: Provided is a composition for wound healing, which includes adenine and a pharmaceutically acceptable salt thereof. Also provided is a method for enhancing wound healing in a subject in need thereof including administering to the subject the composition.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: April 26, 2022
    Assignee: Energenesis Biomedical Co., Ltd.
    Inventors: Han-Min Chen, Cheng-Yi Kuo, Chun-Fang Huang, Jiun-Tsai Lin
  • Method for enhancing wound healing by administrating adenine
    Patent number: 10500206
    Abstract: Provided is a composition for wound healing, which includes adenine and a pharmaceutically acceptable salt thereof. Also provided is a method for enhancing wound healing in a subject in need thereof including administering to the subject the composition.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: December 10, 2019
    Assignee: ENERGENESIS BIOMEDICAL CO., LTD.
    Inventors: Han-Min Chen, Cheng-Yi Kuo, Chun-Fang Huang, Jiun-Tsai Lin
  • Method for activating AMPK and the use of adenine
    Patent number: 10335412
    Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.
    Type: Grant
    Filed: April 10, 2013
    Date of Patent: July 2, 2019
    Assignee: ENERGENESIS BIOMEDICAL CO., LTD
    Inventors: Han-Min Chen, Cheng-Yi Kuo, Chun-Fang Huang, Jiun-Tsai Lin
  • Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
    Patent number: 9938279
    Abstract: The present invention relates to a method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK) and the use of the compounds in the prevention or treatment of disease, including pre-diabetes, type 2 diabetes, syndrome X, metabolic syndrome and obesity.
    Type: Grant
    Filed: April 9, 2013
    Date of Patent: April 10, 2018
    Assignee: ENERGENESIS BIOMEDICAL CO., LTD
    Inventors: Han-Min Chen, Cheng-Yi Kuo, Chun-Fang Huang, Jiun-Tsai Lin
  • Method of promoting hair growth
    Patent number: 9126056
    Abstract: The present invention is an invention belonging to the life style improving cosmetic in the field of hair maintenance and enrichment. More particularly, it relates to cosmetic compositions having an improved hair care actions such as to prevent hair loss and/or to promote hair growth on the scalp and skin of a mammal.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: September 8, 2015
    Assignee: ENERGENESIS BIOMEDICAL CO., LTD.
    Inventors: Han-Min Chen, Li-Te Chin